Holdings
Avidity Partners Management LP
As of Jun 30, 2026, Avidity Partners Management LP reported 40 positions worth US$611M. Largest: Dianthus Therapeutics, Inc., Cg Oncology, Inc. and Oruka Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | 2.1M | US$205M | −2.1M | Jun 30, 2026 |
| Cg Oncology, Inc. | 1.4M | US$99.4M | +110K | Jun 30, 2026 |
| Oruka Therapeutics, Inc. | 760K | US$72.4M | −760K | Jun 30, 2026 |
| Jade Biosciences, Inc. | 1.7M | US$37.8M | −1.1M | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 550K | US$27.9M | −250K | Jun 30, 2026 |
| Perspective Therapeutics, Inc. | 6.3M | US$21.5M | −5.8M | Jun 30, 2026 |
| Aktis Oncology, Inc. | 484K | US$15.6M | −453K | Jun 30, 2026 |
| Palvella Therapeutics, Inc. | 70,000 | US$10.7M | −70,000 | Jun 30, 2026 |
| Mobia Medical, Inc. | 798K | US$10.7M | new | Jun 30, 2026 |
| Repligen Corporation | 77,800 | US$10.6M | −77,800 | Jun 30, 2026 |